Shujun Feng

机构：Tianjin University of Science and Technology, China Pharmaceutical University, Nanjing University of Science and Technology, Hansoh Pharma (China), Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Southern Medical University, Nanjing University · ORCID：0009-0001-4166-6947

发表论文 75 篇 · 总被引 1730 次 · h-index 23

代表论文

• TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson’s Disease Mice and LPS-Induced BV2 Cells (2023 · Molecular Neurobiology · 被引 94)
• The Association of the Glymphatic Function with Parkinson's Disease Symptoms: Neuroimaging Evidence from Longitudinal and Cross‐Sectional Studies (2023 · Annals of Neurology · 被引 72)
• LARS2 Regulates Apoptosis via ROS‐Mediated Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Ovarian Granulosa Cells (2022 · Oxidative Medicine and Cellular Longevity · 被引 66)
• A Gene‐Editable Palladium‐Based Bioorthogonal Nanoplatform Facilitates Macrophage Phagocytosis for Tumor Therapy (2023 · Angewandte Chemie International Edition · 被引 32)
• An Adenovirus‐Mimicking Photoactive Nanomachine Preferentially Invades and Destroys Cancer Cells through Hijacking Cellular Glucose Metabolism (2021 · Advanced Functional Materials · 被引 26)
• Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset (2022 · Parkinsonism & Related Disorders · 被引 24)